We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.79% | 62.50 | 60.00 | 65.00 | 63.00 | 62.50 | 63.00 | 29,011 | 15:03:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.76 | 14.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/6/2021 16:39 | Highest offer today 122p And all those 130.3p trades going through, either way it's going up in the morning people will see those trades and buy especially when they are getting around 10p cheaper | dave4545 | |
28/6/2021 16:37 | Some large transactions have just gone through at 130.3p. Some placees cashing out for a tiny profit or large buys? | investordave | |
28/6/2021 16:06 | NSCI Placing at 130p complete. Management participated despite CEO already owning 20% of Company. Confirm Fair Value is significant premium to current Share Price. Sounding very bullish on underlying investments and Company momentum | the stigologist | |
28/6/2021 16:00 | One of very few shares (that I follow) with such a massive upside vs risk/reward imho. | loafofbread | |
28/6/2021 15:58 | Bloody rampers! (post 3609) | loafofbread | |
28/6/2021 15:56 | There are very few shares that can give you a multiple returns over a short period, NSCI,WSG,ANG, TRMR are a few I have and it's a matter of personal risk, conviction and luck. If everything goes to plan with Proaxis, Glyotest and PDSB over the next six months there is no reason why each one couldn't reach a £50M value, so giving NSCI a market cap of £150M and a share price of £7.00 (21M shares) | loafofbread | |
28/6/2021 15:46 | Kalkaar, that's achievable if especially with Glycotest. Not too sure on time frames! | k1ngkonggb | |
28/6/2021 15:45 | Yeah this should end up hitting between 15 and 20 quid if everything goes to plan | blakieboy7 | |
28/6/2021 15:43 | i'm holding for Loaf's target of £15 ;) that's a mcap of c.£300m+ in case anyone's asking.. | kalkaar | |
28/6/2021 15:38 | Not as low as people selling right now at 119-120p What a market, day traders soon will be selling for 20p profit once paying £8-12 commissions | dave4545 | |
28/6/2021 15:33 | Guys you have very low targets | blakieboy7 | |
28/6/2021 15:32 | That's quite a low target Dave. I'm aiming for at least 250p. | investordave | |
28/6/2021 15:27 | I'm trying to think of a level to sell at. I reckon it can get to 170-180p this time around especially as company have just released a very bullish Rns. Others more long term will obviously aim for higher | dave4545 | |
28/6/2021 15:26 | London, UK - 28 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that at its General Meeting held earlier today in connection with the Placing of £7.7m, all resolutions were duly passed. The Placing remains conditional on the admission of the 5,958,123 New Ordinary Shares to trading on AIM having become effective at 8.00 a.m. on 29 June 2021. This placement culminates a dynamic and successful period, reinforcing the base for continued progress and further growth, including: · Finalisation of a successful turnaround and transformation of the business · Performance and development extended across the Group, and building on the trans-Atlantic relationships · Portfolio companies have reported significant commercial developments which will drive strong future growth even as we emerge from the impact of the COVID-19 pandemic · Fair value has further increased and is up c. 40% on the year end now representing a premium to our market value of 38% · Capital Under Advisory enhanced growth, up c.20% on the year end through several transactions, and demonstrating the capital light model in action John Clarkson, Chairman, stated: "On behalf of the Board I want to express our gratitude to current and new shareholders for their overwhelming vote of support. This demonstrates confidence in the strategy to deliver further progress and shareholder value. The Company is now well positioned for future success." Dr Ilian Iliev, Chief Executive Officer, added: "We are driving ahead with the execution of the business plans and analyst coverage of the Company has now restarted. This combines the use of 'capital-light' investment, pro-active management, value added support to our portfolio, trans-Atlantic synergies, and new opportunities to realise returns." | kalkaar | |
28/6/2021 15:25 | Imbeciles the lot of them. | investordave | |
28/6/2021 15:22 | all good for full placing go ahead and listing tomorrow of new shares.. | kalkaar | |
28/6/2021 15:19 | Love it when this happens. If you sell at silly prices then this is the reward you get. | dave4545 | |
28/6/2021 15:09 | seeing a share I own go up from 108p to 117p in 30 minutes is worth watching kalkaar. my only regret was not buying more this morning....! | 1airbag | |
28/6/2021 14:34 | guys, stop watching intra-day movements - it will drive you insane.. go watch paint dry or something similar | kalkaar | |
28/6/2021 14:31 | I have bought some more shares in NSCI today at its lowest point. I topped up also the other day. There is now a reversal with the share price going up. It bodes well for investors at 130 p. That should really be the floor. A good announcement will propel it to 150 p in no time. | kingston78 | |
28/6/2021 14:28 | Look at all the day trading scumbags pulling in now. | investordave | |
28/6/2021 14:27 | that's why scaling in makes sense with this stock - turns around faster than you can take a leak.. buy when nobody is interested.. sell when the whole world thinks it's going to the moon.. PDSB news overnight: 1 - Brazil senator referring to PDSB's covid vaccine stating trial in a whole town to start next month and that vaccine will be rolled out by end of the year to the whole of Brazil (if successful) 2 - Cantor Fitzgerald initiates research note and PT of $25 (based on Cancer prospects only) | kalkaar |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions